Bioaffinity Technologies Warrant Stock Market Value
| BIAFW Stock | USD 0.60 0.03 5.26% |
| Symbol | BioAffinity |
BioAffinity Technologies Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAffinity Technologies. If investors know BioAffinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAffinity Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.744 | Quarterly Revenue Growth 120.474 | Return On Assets (0.70) | Return On Equity (1.52) |
The market value of BioAffinity Technologies is measured differently than its book value, which is the value of BioAffinity that is recorded on the company's balance sheet. Investors also form their own opinion of BioAffinity Technologies' value that differs from its market value or its book value, called intrinsic value, which is BioAffinity Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAffinity Technologies' market value can be influenced by many factors that don't directly affect BioAffinity Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAffinity Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAffinity Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAffinity Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BioAffinity Technologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioAffinity Technologies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioAffinity Technologies.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in BioAffinity Technologies on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding bioAffinity Technologies Warrant or generate 0.0% return on investment in BioAffinity Technologies over 30 days. BioAffinity Technologies is related to or competes with BioAffinity Technologies,, HUMANA, Barloworld, Morningstar Unconstrained, Thrivent High, and High-yield Municipal. bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targete... More
BioAffinity Technologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioAffinity Technologies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess bioAffinity Technologies Warrant upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 96.67 | |||
| Value At Risk | (26.44) | |||
| Potential Upside | 28.21 |
BioAffinity Technologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioAffinity Technologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioAffinity Technologies' standard deviation. In reality, there are many statistical measures that can use BioAffinity Technologies historical prices to predict the future BioAffinity Technologies' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (3.17) | |||
| Treynor Ratio | 0.257 |
BioAffinity Technologies Backtested Returns
BioAffinity Technologies appears to be out of control, given 3 months investment horizon. BioAffinity Technologies secures Sharpe Ratio (or Efficiency) of 0.0115, which signifies that the company had a 0.0115% return per unit of risk over the last 3 months. We have found twenty-four technical indicators for bioAffinity Technologies Warrant, which you can use to evaluate the volatility of the firm. Please makes use of BioAffinity Technologies' Coefficient Of Variation of (3,604), standard deviation of 17.06, and Risk Adjusted Performance of (0.01) to double-check if our risk estimates are consistent with your expectations. The firm shows a Beta (market volatility) of -1.88, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning BioAffinity Technologies are expected to decrease by larger amounts. On the other hand, during market turmoil, BioAffinity Technologies is expected to outperform it. Please check BioAffinity Technologies' potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to make a quick decision on whether BioAffinity Technologies' price patterns will revert.
Auto-correlation | -0.42 |
Modest reverse predictability
bioAffinity Technologies Warrant has modest reverse predictability. Overlapping area represents the amount of predictability between BioAffinity Technologies time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioAffinity Technologies price movement. The serial correlation of -0.42 indicates that just about 42.0% of current BioAffinity Technologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.42 | |
| Spearman Rank Test | -0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
BioAffinity Technologies lagged returns against current returns
Autocorrelation, which is BioAffinity Technologies stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioAffinity Technologies' stock expected returns. We can calculate the autocorrelation of BioAffinity Technologies returns to help us make a trade decision. For example, suppose you find that BioAffinity Technologies has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioAffinity Technologies regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioAffinity Technologies stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioAffinity Technologies stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioAffinity Technologies stock over time.
Current vs Lagged Prices |
| Timeline |
BioAffinity Technologies Lagged Returns
When evaluating BioAffinity Technologies' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioAffinity Technologies stock have on its future price. BioAffinity Technologies autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioAffinity Technologies autocorrelation shows the relationship between BioAffinity Technologies stock current value and its past values and can show if there is a momentum factor associated with investing in bioAffinity Technologies Warrant.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BioAffinity Stock Analysis
When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.